These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3915528)

  • 21. [A comparison between nicardipine hydrochloride (YC-93) and trimethaphan camsylate for treatment of acute hypertension during surgery. A double blind study in 12 institutions].
    Tamai S; Mori K; Ishii S; Miyazaki M; Sumioka T; Yoshiya I; Enomoto H; Okumura F; Uchida M; Taguchi H
    Masui; 1986 Apr; 35(4):528-39. PubMed ID: 3528551
    [No Abstract]   [Full Text] [Related]  

  • 22. [Systolic hypertension. Treatment with endralazine].
    Kilic S
    ZFA (Stuttgart); 1983 Dec; 59(34):1937-41. PubMed ID: 6367253
    [No Abstract]   [Full Text] [Related]  

  • 23. [Isolated systolic hypertension. "AT1 blocker preferred over beta-blocker"].
    MMW Fortschr Med; 2002 Sep; 144(38):14. PubMed ID: 12395694
    [No Abstract]   [Full Text] [Related]  

  • 24. [Value of a blood pressure profile in evaluating 2 antihypertensive agents].
    Abetel G; Mérier G; Karly M; Genoud A; Bousquet JC
    Schweiz Med Wochenschr; 1984 Dec; 114(48):1746-9. PubMed ID: 6151741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A report of the treatment of isolated systemic hypertension in the elderly patients (5 years follow up)].
    Sun M; Zhou H; Xie X; Wu S; Ma Q
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(4):388-90. PubMed ID: 11189402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Should systolic hypertension in the elderly be treated?].
    Ozawa T
    Kokyu To Junkan; 1985 Mar; 33(3):263-6. PubMed ID: 4012050
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapeutic decision-making in systolic hypertension.
    Chobanian AV
    Geriatrics; 1981 Mar; 36(3):36-43. PubMed ID: 7011905
    [No Abstract]   [Full Text] [Related]  

  • 28. [Isolated systolic hypertension in the elderly].
    Arabidze GG; Fagard R; Petrov VV; Staessen J
    Ter Arkh; 1996; 68(11):77-82. PubMed ID: 9045391
    [No Abstract]   [Full Text] [Related]  

  • 29. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist.
    Andrén L; Svensson A; Dahlöf B; Eggertsen R; Hansson L
    Acta Med Scand; 1983; 214(2):125-30. PubMed ID: 6353879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilot study of antihypertensive treatment in the elderly.
    Penman WA; Smith RG
    Practitioner; 1982 Jun; 226(1368):1180-2. PubMed ID: 7050951
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of isolated systolic hypertension in the elderly].
    Hilden T; Ibsen H
    Ugeskr Laeger; 1992 Aug; 154(35):2375-7. PubMed ID: 1413155
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antihypertensive effectiveness of a guanfacine/clopamide combination].
    Wetzels E; Weidinger G
    MMW Munch Med Wochenschr; 1982 Oct; 124(40):871-4. PubMed ID: 6815503
    [No Abstract]   [Full Text] [Related]  

  • 33. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of the treatment of arterial hypertension in the elderly subject].
    Amery A; De Schaepdryver A
    Therapie; 1986; 41(6):473-80. PubMed ID: 3544324
    [No Abstract]   [Full Text] [Related]  

  • 35. Trials of the treatment of mild hypertension. An interim analysis.
    Lancet; 1982 Jan; 1(8264):149-56. PubMed ID: 6119523
    [No Abstract]   [Full Text] [Related]  

  • 36. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of a new alpha-adrenoceptor agonist, guanfacine and alpha-methyldopa in the treatment of hypertension.
    Joshi RC; De A; Cameron EG
    Br J Clin Pract; 1984 Feb; 38(2):66-7, 71. PubMed ID: 6142723
    [No Abstract]   [Full Text] [Related]  

  • 38. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
    Rhomberg F; Widler J
    Schweiz Med Wochenschr; 1981 Dec; 111(50):1967-8. PubMed ID: 7036334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of our understanding of the importance of elevated systolic blood pressure.
    Applegate WB
    Tenn Med; 1997 Jan; 90(1):24-6. PubMed ID: 8997159
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of the SYST-EUR study. Isolated systolic hypertension and calcium antagonists].
    Faulhaber HD
    Fortschr Med; 1997 Nov; 115(32):45-6. PubMed ID: 9480267
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.